Delivery Order 36F79719D0108-36C24522N0505
Award Date
5/17/22
Potential Completion Date
5/19/22
Potential Value
$19K
Federal Agency
Veterans Integrated Service Network 5
Awardee
Amicus Therapeutics US, LLC
Ultimate Awardee
Amicus Therapeutics, Inc.
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Philadelphia, PA 19104, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $18,888.46 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule to Amicus Therapeutics US, LLC. The firm fixed price order is for GALAFOLD 123 MG and has a completion date of July 8, 2022. Amicus Therapeutics US, LLC is a subsidiary of Amicus Therapeutics, Inc., which is currently operating as a development stage company. Place of performance will be in...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $20,124.91 delivery order against the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule to Amicus Therapeutics US, LLC for GALAFOLD 123 MG. The firm fixed price order has a completion date of February 9, 2023 and was awarded on February 7, 2023. Amicus Therapeutics US, LLC is a subsidiary of Amicus Therapeutics, Inc., which is currently operating as a development stage company....
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $20,124.91 delivery order against the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule to Amicus Therapeutics US, LLC for GALAFOLD 123 MG. The firm fixed price order has a completion date of January 9, 2023 and was awarded on January 5, 2023. Amicus Therapeutics US, LLC is a subsidiary of Amicus Therapeutics, Inc., which is currently operating as a development stage company....
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded Amicus Therapeutics US, LLC a $20,124.91 firm fixed price delivery order for GALAFOLD 123 MG under the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule. Amicus Therapeutics US, LLC is a subsidiary of Amicus Therapeutics, Inc., which is developing novel, first-in-class pharmaceuticals for rare and orphan diseases. The delivery order is for the drug GALAFOLD and has a potential value...
The Department of Veterans Affairs Veterans Health Administration awarded a $20,125 delivery order against Amicus Therapeutics US, LLC's Pharmaceuticals and Drugs GSA Schedule contract. Amicus Therapeutics US, LLC, a subsidiary of Amicus Therapeutics, Inc., will provide GALAFOLD 123 MG to Veterans Integrated Service Network 5 in Philadelphia, Pennsylvania from December 6-8, 2023. The firm fixed price order supports the VA's mission to provide quality healthcare to veterans through its Veterans...
The Department of Veterans Affairs Veterans Health Administration awarded a $20,125 delivery order against Amicus Therapeutics US, LLC's Pharmaceuticals and Drugs GSA Schedule contract. Amicus Therapeutics US, LLC, a subsidiary of Amicus Therapeutics, Inc., will provide GALAFOLD 123 MG to Veterans Integrated Service Network 5 in Philadelphia, Pennsylvania between August 31 and September 6, 2023. The firm fixed price order is funded by VA-VHA to support its mission of providing healthcare...
The Department of Veterans Affairs Veterans Health Administration awarded a $20,125 firm fixed price delivery order against Amicus Therapeutics US, LLC's GSA Schedule Pharmaceuticals and Drugs contract. Amicus Therapeutics US, LLC, a subsidiary of Amicus Therapeutics, Inc., will provide GALAFOLD 123 MG to the VA - VHA Veterans Integrated Service Network 5 in Philadelphia, Pennsylvania. The delivery order has a period of performance from December 27, 2023 through December 29, 2023 to support...
The Department of Veterans Affairs Veterans Health Administration awarded a $20,125 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule to Amicus Therapeutics US, LLC for GALAFOLD 123 MG. As the prime contractor, Amicus Therapeutics US will provide the medication to support Veterans Integrated Service Network 5's programs. Amicus Therapeutics, Inc. is the parent company of the prime contractor. Performance will take place in Philadelphia, Pennsylvania over a period of...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a delivery order against the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule to Amicus Therapeutics US, LLC for $20,124.91. The firm fixed price order is for GALAFOLD 123 MG and has a completion date of May 19, 2023. Amicus Therapeutics US, LLC is a subsidiary of Amicus Therapeutics, Inc., which is currently operating as a development stage company. The order was awarded on May...
Amicus Therapeutics US, LLC, a subsidiary of Amicus Therapeutics, Inc., has been awarded a $18,888.46 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The firm fixed price order is for the delivery of GALAFOLD 123 MG to the Philadelphia, PA location, with performance to be completed by August 9, 2022. The contract utilizes the GSA Schedule master agreement for...